Interviews | Page 8

myths-and-hysteria-surrounding-the-use-of-opioids-for-non-cancer-pain
Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses and debunks the myths and hysteria surrounding the use of opioid therapy in treating non-cancer pain.
conditions-that-make-patients-more-or-less-likely-to-experience-opioid-induced-constipation
Daniel T. Abazia, PharmD, BCPS, outlines some of the factors that might contribute to a patient's propensity to experience opioid-induced constipation.
the-effects-of-expanded-naloxone-access
Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses the effects of expanded naloxone access.
why-is-obesity-considered-a-chronic-disease
Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, professor and department chair for Pharmacy Practice, University of Mississippi School of Pharmacy, explains why obesity is considered a chronic disease.
monitoring-for-hypoglycemia-in-type-2-diabetics-on-second-line-therapies-
Susan Cornell, PharmD, CDE, FAPhA, FAADE, offers tips for how pharmacists can monitor for hypoglycemia in type 2 diabetics on second-line therapies.
the-obstacles-of-improving-naloxone-access
Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses the obstacles that pharmacists are encountering as naloxone access continues to improve.
strategies-to-enhance-the-safe-use-of-chronic-opioid-therapy
Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses strategies pharmacists can employ to enhance the safe use of chronic opioid therapy.
strategies-for-combatting-pet-and-dust-allergies-within-the-home
Dennis Williams, PharmD, FAPhA, talks about ways to prevent allergies related to pets and dust.
strategies-to-select-the-most-appropriate-second-line-therapy-for-diabetics-
Susan Cornell, PharmD, CDE, FAPhA, FAADE, outlines some strategies for pharmacists tasked with selecting the most appropriate second-line therapy for their patients with type 2 diabetes.
comorbid-conditions-that-may-influence-asthma-and-copd-treatment-selection-and-dosing
Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses what comorbid conditions to look out for among asthma and COPD patients.
$AD300x250BB$
Latest Issues
$auto_registration$